Abundance Wealth Counselors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.02M | Sell |
27,335
-820
| -3% | -$90.5K | 0.57% | 30 |
|
|
2025
Q1 | $3.14M | Buy |
28,155
+443
| +2% | +$49.4K | 0.66% | 26 |
|
|
2024
Q4 | $2.56M | Sell |
27,712
-174
| -0.6% | -$16.1K | 0.56% | 27 |
|
|
2024
Q3 | $2.34M | Buy |
+27,886
| New | +$2.34M | 0.48% | 27 |
|
|
2024
Q2 | – | Sell |
-26,673
| Closed | -$1.95M | – | 89 |
|
|
2024
Q1 | $1.95M | Buy |
26,673
+1,084
| +4% | +$79.4K | 0.45% | 33 |
|
|
2023
Q4 | $2.07M | Buy |
25,589
+492
| +2% | +$39.9K | 0.54% | 32 |
|
|
2023
Q3 | $1.88M | Buy |
+25,097
| New | +$1.88M | 0.54% | 30 |
|
|
2023
Q2 | – | Sell |
-26,018
| Closed | -$2.16M | – | 89 |
|
|
2023
Q1 | $2.16M | Sell |
26,018
-1,789
| -6% | -$148K | 0.55% | 26 |
|
|
2022
Q4 | $2.39M | Buy |
27,807
+215
| +0.8% | +$18.5K | 0.65% | 23 |
|
|
2022
Q3 | $1.7M | Buy |
27,592
+634
| +2% | +$39.1K | 0.49% | 28 |
|
|
2022
Q2 | $1.67M | Buy |
26,958
+1,225
| +5% | +$75.7K | 0.45% | 33 |
|
|
2022
Q1 | $1.53M | Buy |
25,733
+851
| +3% | +$50.6K | 0.42% | 39 |
|
|
2021
Q4 | $1.81M | Buy |
+24,882
| New | +$1.81M | 0.46% | 27 |
|
|
2021
Q3 | – | Sell |
-23,386
| Closed | -$1.61M | – | 65 |
|
|
2021
Q2 | $1.61M | Buy |
23,386
+8,717
| +59% | +$600K | 0.42% | 26 |
|
|
2021
Q1 | $948K | Buy |
14,669
+3,945
| +37% | +$255K | 0.24% | 47 |
|
|
2020
Q4 | $625K | Buy |
10,724
+1,054
| +11% | +$61.4K | 0.16% | 61 |
|
|
2020
Q3 | $611K | Buy |
9,670
+3,965
| +70% | +$251K | 0.18% | 57 |
|
|
2020
Q2 | $439K | Buy |
+5,705
| New | +$439K | 0.13% | 65 |
|